Here we present the genetic and phenotypic analysis of a PIK3CA mutated subgroup within a cohort of 1144 NSCLC patients consecutively collected over a period of two years in a molecular screening network for lung cancer. This evidence concerns the gene PIK3CA and non-small cell lung carcinoma.